table of content
1 Prostate Specific Antigen Market Overview
1.1 Product Overview and Scope of Prostate Specific Antigen
1.2 Prostate Specific Antigen Segment by Type
1.2.1 Global Prostate Specific Antigen Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 G-115
1.2.3 INO-5150
1.2.4 ADXS-PSA
1.2.5 AEZS-120
1.2.6 Others
1.3 Prostate Specific Antigen Segment by Application
1.3.1 Global Prostate Specific Antigen Sales Comparison by Application: (2022-2028)
1.3.2 Prostate Cancer
1.3.3 Metastatic Hormone Refractory Prostate Cancer
1.3.4 Others
1.4 Global Prostate Specific Antigen Market Size Estimates and Forecasts
1.4.1 Global Prostate Specific Antigen Revenue 2017-2028
1.4.2 Global Prostate Specific Antigen Sales 2017-2028
1.4.3 Prostate Specific Antigen Market Size by Region: 2017 Versus 2021 Versus 2028
2 Prostate Specific Antigen Market Competition by Manufacturers
2.1 Global Prostate Specific Antigen Sales Market Share by Manufacturers (2017-2022)
2.2 Global Prostate Specific Antigen Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Prostate Specific Antigen Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Prostate Specific Antigen Manufacturing Sites, Area Served, Product Type
2.5 Prostate Specific Antigen Market Competitive Situation and Trends
2.5.1 Prostate Specific Antigen Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Prostate Specific Antigen Players Market Share by Revenue
2.5.3 Global Prostate Specific Antigen Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prostate Specific Antigen Retrospective Market Scenario by Region
3.1 Global Prostate Specific Antigen Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Prostate Specific Antigen Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Prostate Specific Antigen Market Facts & Figures by Country
3.3.1 North America Prostate Specific Antigen Sales by Country
3.3.2 North America Prostate Specific Antigen Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Prostate Specific Antigen Market Facts & Figures by Country
3.4.1 Europe Prostate Specific Antigen Sales by Country
3.4.2 Europe Prostate Specific Antigen Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Prostate Specific Antigen Market Facts & Figures by Region
3.5.1 Asia Pacific Prostate Specific Antigen Sales by Region
3.5.2 Asia Pacific Prostate Specific Antigen Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Prostate Specific Antigen Market Facts & Figures by Country
3.6.1 Latin America Prostate Specific Antigen Sales by Country
3.6.2 Latin America Prostate Specific Antigen Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Prostate Specific Antigen Market Facts & Figures by Country
3.7.1 Middle East and Africa Prostate Specific Antigen Sales by Country
3.7.2 Middle East and Africa Prostate Specific Antigen Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Prostate Specific Antigen Historic Market Analysis by Type
4.1 Global Prostate Specific Antigen Sales Market Share by Type (2017-2022)
4.2 Global Prostate Specific Antigen Revenue Market Share by Type (2017-2022)
4.3 Global Prostate Specific Antigen Price by Type (2017-2022)
5 Global Prostate Specific Antigen Historic Market Analysis by Application
5.1 Global Prostate Specific Antigen Sales Market Share by Application (2017-2022)
5.2 Global Prostate Specific Antigen Revenue Market Share by Application (2017-2022)
5.3 Global Prostate Specific Antigen Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Advaxis, Inc.
6.1.1 Advaxis, Inc. Corporation Information
6.1.2 Advaxis, Inc. Description and Business Overview
6.1.3 Advaxis, Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Advaxis, Inc. Prostate Specific Antigen Product Portfolio
6.1.5 Advaxis, Inc. Recent Developments/Updates
6.2 Aeterna Zentaris Inc.
6.2.1 Aeterna Zentaris Inc. Corporation Information
6.2.2 Aeterna Zentaris Inc. Description and Business Overview
6.2.3 Aeterna Zentaris Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Aeterna Zentaris Inc. Prostate Specific Antigen Product Portfolio
6.2.5 Aeterna Zentaris Inc. Recent Developments/Updates
6.3 Bavarian Nordic A/S
6.3.1 Bavarian Nordic A/S Corporation Information
6.3.2 Bavarian Nordic A/S Description and Business Overview
6.3.3 Bavarian Nordic A/S Prostate Specific Antigen Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Bavarian Nordic A/S Prostate Specific Antigen Product Portfolio
6.3.5 Bavarian Nordic A/S Recent Developments/Updates
6.4 Curevac AG
6.4.1 Curevac AG Corporation Information
6.4.2 Curevac AG Description and Business Overview
6.4.3 Curevac AG Prostate Specific Antigen Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Curevac AG Prostate Specific Antigen Product Portfolio
6.4.5 Curevac AG Recent Developments/Updates
6.5 GenSpera, Inc.
6.5.1 GenSpera, Inc. Corporation Information
6.5.2 GenSpera, Inc. Description and Business Overview
6.5.3 GenSpera, Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2017-2022)
6.5.4 GenSpera, Inc. Prostate Specific Antigen Product Portfolio
6.5.5 GenSpera, Inc. Recent Developments/Updates
6.6 Inovio Pharmaceuticals, Inc.
6.6.1 Inovio Pharmaceuticals, Inc. Corporation Information
6.6.2 Inovio Pharmaceuticals, Inc. Description and Business Overview
6.6.3 Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Product Portfolio
6.6.5 Inovio Pharmaceuticals, Inc. Recent Developments/Updates
6.7 OncBioMune Pharmaceuticals Inc.
6.6.1 OncBioMune Pharmaceuticals Inc. Corporation Information
6.6.2 OncBioMune Pharmaceuticals Inc. Description and Business Overview
6.6.3 OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2017-2022)
6.4.4 OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Product Portfolio
6.7.5 OncBioMune Pharmaceuticals Inc. Recent Developments/Updates
7 Prostate Specific Antigen Manufacturing Cost Analysis
7.1 Prostate Specific Antigen Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Prostate Specific Antigen
7.4 Prostate Specific Antigen Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Prostate Specific Antigen Distributors List
8.3 Prostate Specific Antigen Customers
9 Prostate Specific Antigen Market Dynamics
9.1 Prostate Specific Antigen Industry Trends
9.2 Prostate Specific Antigen Market Drivers
9.3 Prostate Specific Antigen Market Challenges
9.4 Prostate Specific Antigen Market Restraints
10 Global Market Forecast
10.1 Prostate Specific Antigen Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Prostate Specific Antigen by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Prostate Specific Antigen by Type (2023-2028)
10.2 Prostate Specific Antigen Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Prostate Specific Antigen by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Prostate Specific Antigen by Application (2023-2028)
10.3 Prostate Specific Antigen Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Prostate Specific Antigen by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Prostate Specific Antigen by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
